Epimedin C could alleviate glucocorticoid-induced suppression of osteogenic differentiation by modulating the PI3K/AKT/Runx2 signaling pathway. Icariin alleviates osteoporosis through EphB4/Ephrin-B2 axis. Here, RUNX2 is linked to osteoporosis.